![](https://investorshub.advfn.com/uicon/60294.png?cb=1611719355)
Saturday, November 01, 2014 5:08:45 AM
From the FDA:
We have said that a class-wide requirement is not feasible or in the interests of public health at this time.
But the agency did give some signal that it may eventually call for all opioids to have abuse-deterrent properties.
If the above should eventually happen how valuable would this company become? And given Hikes conservative number crunching for even a 10% capture of the prescription opioid market by Elite what would the share price be if the FDA required all prescription opioids to have ADT/ART properties included? Elite being the best currently out there.
Lots of companies would either have to license or partner with Elite.
So dont be too hasty with the buyout scenario. Could happen but then again there are also other forces in motion here.
Time will tell.
As for the high risk investing in Elite... that was over in 2011-2012 when the company turned itself around under Jerry.
Now that Elite is no longer a going concern... the risk has become even smaller. Elite is on the cusp of getting approval for their ADT/ART technology by the FDA. The stakes are very slight at this point. Nasrat is hardly a high roller. His moves are well planned and calculated by a man who knows exactly what he is doing. He has surrounded himself with an excellent staff and recently bolstered this staff with regulatory, legal, and formulations/analytical personnel whose backgrounds suggest a good deal of experience with Big Pharma.
Cannot stop what is to come. ART is coming from Elite to an opioid nearby.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM